| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030080258 |
| P356 | DOI | 10.1186/1755-8794-8-S1-S6 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/1755-8794-8-s1-s6 |
| P932 | PMC publication ID | 4315320 |
| P698 | PubMed publication ID | 25952014 |
| P50 | author | Sudhir Kumar | Q38053058 |
| P2093 | author name string | Li Liu | |
| Eric D Thomas | |||
| Kristyn Gerold | |||
| Nevin Z Gerek | |||
| Pegah Biparva | |||
| P2860 | cites work | Understanding human disease mutations through the use of interspecific genetic variation | Q43572665 |
| Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity | Q44221551 | ||
| Adverse drug reaction deaths reported in United States vital statistics, 1999-2006. | Q45897405 | ||
| A SNPshot of PubMed to associate genetic variants with drugs, diseases, and adverse reactions | Q47798831 | ||
| Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease. | Q53370571 | ||
| Clinical application of pharmacogenetics | Q73812542 | ||
| Predicting deleterious amino acid substitutions | Q22065761 | ||
| Pharmacogenetics, pharmacogenomics, and individualized medicine | Q23919667 | ||
| Amino acid substitution matrices from protein blocks | Q24563220 | ||
| Exome sequencing identifies the cause of a mendelian disorder | Q24607742 | ||
| Targeted capture and massively parallel sequencing of 12 human exomes | Q24615381 | ||
| Pharmacogenomics knowledge for personalized medicine | Q24623166 | ||
| The UCSC Genome Browser database: update 2011 | Q24625811 | ||
| From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource | Q24632079 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin | Q29417159 | ||
| Human non-synonymous SNPs: server and survey | Q29547603 | ||
| Amino acid difference formula to help explain protein evolution | Q29614440 | ||
| Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies | Q29616299 | ||
| Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease | Q29619085 | ||
| Sparse Methods for Biomedical Data | Q30670592 | ||
| The incidence and nature of in-hospital adverse events: a systematic review | Q34783812 | ||
| Bioinformatics and variability in drug response: a protein structural perspective | Q36009999 | ||
| Drug metabolism and variability among patients in drug response | Q36139862 | ||
| Evolutionary balancing is critical for correctly forecasting disease-associated amino acid variants | Q36830862 | ||
| Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing | Q37086591 | ||
| Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes | Q37173576 | ||
| Evolutionary diagnosis method for variants in personal exomes | Q37262449 | ||
| Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer | Q37528144 | ||
| Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects. | Q37585393 | ||
| A useful tool for drug interaction evaluation: the University of Washington Metabolism and Transport Drug Interaction Database | Q37812191 | ||
| The ApoE gene of Alzheimer's disease (AD). | Q37902560 | ||
| Inferring causality and functional significance of human coding DNA variants | Q38044611 | ||
| Omics and drug response | Q38058836 | ||
| Positional conservation and amino acids shape the correct diagnosis and population frequencies of benign and damaging personal amino acid mutations | Q39968902 | ||
| Lessons from 60 years of pharmaceutical innovation | Q43447062 | ||
| P304 | page(s) | S6 | |
| P577 | publication date | 2015-01-15 | |
| P1433 | published in | BMC Medical Genomics | Q15754662 |
| P1476 | title | Evolutionary Diagnosis of non-synonymous variants involved in differential drug response | |
| P478 | volume | 8 Suppl 1 |
| Q38735331 | A Computational Approach to Identify a Potential Alternative Drug With Its Positive Impact Toward PMP22. |
| Q60907336 | Biological relevance of computationally predicted pathogenicity of noncoding variants |
| Q52655829 | DROIDS 1.20: A GUI-Based Pipeline for GPU-Accelerated Comparative Protein Dynamics. |
| Q60957982 | Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients |
Search more.